Early use of tacrolimus as rescue therapy for refractory liver allograft rejection

Transplant International

Volumn 11, Issue SUPPL. 1, 1998, Pages

  Charco, R ^a   Murio, E ^a   Edo, A ^a   Balsells, J ^a   Lazaro J L ^a   Bilbao, I ^a   Hidalgo, E ^a   Margarit, C ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Hepatitis C virus; Liver transplantation; Refractory rejection; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; GRAFT REJECTION; HUMAN; LIVER TRANSPLANTATION; TIME;

GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; TACROLIMUS; TIME FACTORS;

EID: 0031608943     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1998.tb01142.x     Document Type: Article

References (19)

1. Jonas S, Bechstein WO, Lemmens HP, Kling N, Grauhan O, Lobeck H, Neuhaus P (1996) Conversion to tacrolimus after liver transplantation. Transpl Int 9: 23-31
2. Neuberger J, Elias E (1995) Immunosuppressive agents. In: Maddrey WC, Sorrell MF (eds) Transplantation of the liver. Appleton and Lange, Norwalk, pp 247-265
3. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J (1992) Hepatitis C viral infection in liver transplant recipients. Hepatology 16: 865-876
4. Jordan ML, Shapiro R, Vivas CA, Scantlebury PV, Rhandhawa P, Carrieri G, McCauley J, Demetris AJ, Tzakis A, Funf J, Simmons RL, Hakala TR, Starlz T (1994) FK 506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 57: 860-865
5. Demetris AJ, Fung JJ, Todo S, McCauley J, Jain A, Takaya S, Alessiani M, Abu-Elmagd K, Van Thiel DH, Starzl T (1992) Conversion of liver allograft recipients from cyclosporine to FK 506 immunosuppressive therapy. A clinicopathologic study of 96 patients. Transplantation 53: 1056-1062
6. Sher LS, Cosenza CA, Petrovic LM, Rotjer S, Hoffman A, Lopez RR, Meehan M, Pan SH, Vierling, Makowka L (1996) Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation. Transplant Proc 28: 1011-1013
7. The US Multicenter FK 506 Liver Study Group (1994) A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 331: 1110-1115
8. European FK 506 Liver Study Group (1994) Randomised trial comparing tacrolimus (FK 506) and cyclosporine in prevention of liver allograft rejection. Lancet 344: 423-428
9. Platz KP, Muller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H (1995) OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection. Transplant Proc 27: 1111-1113
10. Murio JE, Balsells J, Lázaro JL, Charco R, Margarit C (1995) Compassionate use of FK 506 in liver transplantation. Transplant Proc 27: 2336
11. Charco R, Ruiz C, Allende E, Lázaro JL, Murio E, Bilbao I, Gifre E, Margarit C (1995) Experience in therapy of chronic liver allograft rejection. Transplant Proc 27: 2293-2294
12. International Working Party (1995) Terminology for hepatic allograft rejection. Hepatology 22: 648-654
13. Mor E, Solomon H, Gibbs J, Holman MJ, Goldstein RM, Husberg BOS, Gonwa TA, Klintmalm (1992) Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome. Semin Liver Dis 12: 28-40
14. Bismuth H for the European FK 506 Multicenter Liver Study Group (1995) Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. Transplant Proc 27: 45-49
15. Demetris AJ, Murase N, Delaney M, Woan JJ, Starzl TE (1995) The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us? Transplant Proc 27: 67-70
16. Gane EJ, Portmann BC, Naumov NV, Smith HM, Underbill JA, Donalson PT, Maertens G, Williams R (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334: 815-820
17. Ludwing J, Wiesner R, Batts K, Perkins J, Krom R (1987) The acute vanishing bile duct syndrome (acute reversible rejection) after orthotopic liver transplantation. Hepatology 7: 474-478
18. Charco R, Vargas V, Allende H, Edo A, Balsells J, Murio E, Lázaro JL, Bilbao I, Margarit C (1996) Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection? (Suppl 1) 9: S195-197
19. Winkler M, Haller G, Oldhafer K, Bechstein WO, Kattner A, Maibucher A, Farber L, Ringe B, Christians U, Neuhaus P, Pichlmayr R (1996) A new oral formulation of cyclosporine for early oral immunosuppressive therapy in liver transplant recipients. Transplantation 62: 1063-1068